Status:
COMPLETED
Validation of the Two-minute Walk Test and the Ten-meter Walk Test in Individuals With Cancer
Lead Sponsor:
Aline Reinmann
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to assess the feasibility and the validity of the 2-minute walk test (2MWT) and the 10-meter walk test (10MeWT) compared to the 6-minute walk test (6MWT) for subjects with onc...
Detailed Description
Cancer and its treatments have an impact on the body as a whole. The analysis of the subject's physical capacity is essential to know the basic level of the subject pre-treatment, to evaluate progress...
Eligibility Criteria
Inclusion
- Have an onco-hematologic disease
- Have medical authorization from the patient's oncologist authorizing gait tests
- Participate in the HUG rehabilitation program
- Be able to give consent by signature
- To be of legal age
- Do not present pain when walking more than 2/10
- Be able to walk with or without technical aids for a period of 6 minutes (as per patient's statement)
Exclusion
- Suffer from heart problems
- Bone metastases at risk of fracture
- Osteoporosis at high risk of fracture
- Unbalanced Hypertension (hypertension)
- Not being able to carry out the walk tests in their entirety
- Not being able to perform the gait tests for reasons related to the side effects of the treatments (anemia, undernutrition, vomiting, severe fatigue, risk of thrombocytopenia, pain).
- Not being able to carry out the walking test because of a lack of understanding of the instructions or because of psychological problems.
Key Trial Info
Start Date :
February 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04750148
Start Date
February 15 2021
End Date
March 31 2021
Last Update
January 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospitals
Geneva, Switzerland, 1205